STOCK TITAN

[Form 4] CARTERS INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Hali Borenstein, a director of Carter's, Inc. (CRI), received 16.8031 shares of the issuer's common stock on 09/12/2025 at no cash cost under the companys director deferred compensation program. Following the transaction, the reporting persons total beneficial ownership is reported as 16,991.8143 shares. The Form 4 was filed by one reporting person and signed by an attorney-in-fact on 09/12/2025. The filing explains these shares were credited as a dividend payment and will be settled pursuant to the deferred compensation plan.

Hali Borenstein, una direttrice di Carter's, Inc. (CRI), ha ricevuto 16.8031 azioni ordinarie dell’emittente il 12/09/2025 senza alcun costo in contanti nell’ambito del programma di compensazione differita per i direttori dell’azienda. Dopo la transazione, la proprietàBeneficiaria Totale riportata è di 16.991.8143 azioni. Il Modulo 4 è stato presentato da una persona dichiarante e firmato da un procuratore il 12/09/2025. Il modulo spiega che queste azioni sono state accreditate come pagamento di dividendi e saranno regolate ai sensi del piano di compensazione differita.

Hali Borenstein, directora de Carter's, Inc. (CRI), recibió 16.8031 acciones ordinarias del emisor el 12/09/2025 sin costo en efectivo, bajo el programa de compensación diferida para directores de la empresa. Tras la transacción, la participación total de propiedad beneficiosa reportada es de 16.991.8143 acciones. El Formulario 4 fue presentado por una persona informante y firmado por un apoderado el 12/09/2025. El documento explica que estas acciones fueron creditadas como pago de dividendos y serán liquidadas conforme al plan de compensación diferida.

헤일 보렌스타인(Hali Borenstein)은 Carter's, Inc. (CRI)의 이사로서 2025년 9월 12일 현금 없이 발행사 보통주 16.8031주를 수령했습니다. 이는 회사의 이사용 지연 보상 제도 하에서 이루어졌습니다. 거래 후 보고자의 총 유익 보유 주식수는 16.991.8143주로 보고됩니다. Form 4는 한 명의 보고자가 제출했고 2025년 9월 12일 대리인에 의해 서명되었습니다. 공시에는 이 주식이 배당금으로 적립되었고 지연 보상 계획에 따라 결제될 것이라고 설명되어 있습니다.

Hali Borenstein, administratrice chez Carter's, Inc. (CRI), a reçu 16,8031 actions ordinaires de l’émetteur le 12/09/2025 sans coût cash, dans le cadre du programme de rémunération différée des administrateurs de l’entreprise. Suite à la transaction, la détention bénéficiaire totale reportée est de 16.991.8143 actions. Le Formulaire 4 a été déposé par une personne déclarant et signé par un mandataire le 12/09/2025. Le dépôt explique que ces actions ont été créditées en tant que paiement de dividendes et seront réglées conformément au plan de rémunération différée.

Hali Borenstein, eine Direktorin bei Carter's, Inc. (CRI), hat am 12.09.2025 16,8031 Stammaktien des Emittenten ohne Bareinzahlung im Rahmen des Vorstands- deferred compensation-Programms erhalten. Nach der Transaktion wird das insgesamt gemeldete beherrschende Eigentum mit 16.991.8143 Aktien angegeben. Das Formular 4 wurde von einer meldenden Person eingereicht und am 12.09.2025 von einem Prokuristen unterzeichnet. Die Einreichung erklärt, dass diese Aktien als Dividendenzahlung gutgeschrieben wurden und gemäß dem Deferred-Compensation-Plan abgewickelt werden.

هيلى بورنسترن، مديرة في Carter's, Inc. (CRI)، تلقّت 16.8031 سهماً عاديّاً للمُصدر في 12/09/2025 بدون أي تكلفة نقدية، ضمن برنامج تعويضات مديرين مؤجَّلة للشركة. عقب الصفقة، تُذكر الملكية المفيدة الإجمالية للمُعلَن عنها كـ16.991.8143 سهماً. تم تقديم النموذج 4 من قبل شخص مُصرّح به وتوقيعه من قبل وكيل مفوَّض في 12/09/2025. يشرح المستند أن هذه الأسهم أُدرِجَت كدفعة أرباح وسيتم تسويتها وفقاً لخطة التعويض المؤجَّل.

Hali Borenstein,Carter's, Inc. (CRI) 的董事,于2025年9月12日,在公司的董事延期补偿计划下,获得了16.8031股发行人普通股,未产生现金成本。交易后,报告人总受益所有权被记为16,991.8143股。Form 4 由一名申报人提交,并由代理人于2025年9月12日签署。申报文件说明这些股票被记入股息支付,并将按照延期补偿计划进行结算。

Positive
  • Director received equity compensation via the company's deferred compensation program, aligning director interests with shareholders
  • Transaction is administrative and non-cash, indicating no immediate insider selling pressure
Negative
  • None.

Insights

TL;DR: Director received a small number of shares via deferred compensation dividend; routine, non-cash transaction with limited investor impact.

The Form 4 documents a typical director compensation settlement: 16.8031 common shares were credited at $0 under the companys director deferred compensation program and added to the reporting persons beneficial holdings, bringing the total to 16,991.8143 shares. This is an administrative issuance tied to compensation and dividends rather than a market purchase or sale. There is no indication of exercise of options, cash consideration, or changes to board status. Materiality to shareholders is minimal given the small number of shares and the non-cash nature of the transaction.

TL;DR: Reported issuance is a dividend-related credit to a director's deferred compensation account; not a market-moving event.

The transaction date is 09/12/2025 and the filing shows an acquisition code (A) of 16.8031 shares at a reported price of $0, consistent with shares issued as compensation/dividend credits. The filing was singular (one reporting person) and executed by an attorney-in-fact. No derivative transactions, dispositions, or other securities activity are reported. For investors focused on insider trading activity, this entry signals routine compensation mechanics rather than insider buying or selling based on corporate developments.

Hali Borenstein, una direttrice di Carter's, Inc. (CRI), ha ricevuto 16.8031 azioni ordinarie dell’emittente il 12/09/2025 senza alcun costo in contanti nell’ambito del programma di compensazione differita per i direttori dell’azienda. Dopo la transazione, la proprietàBeneficiaria Totale riportata è di 16.991.8143 azioni. Il Modulo 4 è stato presentato da una persona dichiarante e firmato da un procuratore il 12/09/2025. Il modulo spiega che queste azioni sono state accreditate come pagamento di dividendi e saranno regolate ai sensi del piano di compensazione differita.

Hali Borenstein, directora de Carter's, Inc. (CRI), recibió 16.8031 acciones ordinarias del emisor el 12/09/2025 sin costo en efectivo, bajo el programa de compensación diferida para directores de la empresa. Tras la transacción, la participación total de propiedad beneficiosa reportada es de 16.991.8143 acciones. El Formulario 4 fue presentado por una persona informante y firmado por un apoderado el 12/09/2025. El documento explica que estas acciones fueron creditadas como pago de dividendos y serán liquidadas conforme al plan de compensación diferida.

헤일 보렌스타인(Hali Borenstein)은 Carter's, Inc. (CRI)의 이사로서 2025년 9월 12일 현금 없이 발행사 보통주 16.8031주를 수령했습니다. 이는 회사의 이사용 지연 보상 제도 하에서 이루어졌습니다. 거래 후 보고자의 총 유익 보유 주식수는 16.991.8143주로 보고됩니다. Form 4는 한 명의 보고자가 제출했고 2025년 9월 12일 대리인에 의해 서명되었습니다. 공시에는 이 주식이 배당금으로 적립되었고 지연 보상 계획에 따라 결제될 것이라고 설명되어 있습니다.

Hali Borenstein, administratrice chez Carter's, Inc. (CRI), a reçu 16,8031 actions ordinaires de l’émetteur le 12/09/2025 sans coût cash, dans le cadre du programme de rémunération différée des administrateurs de l’entreprise. Suite à la transaction, la détention bénéficiaire totale reportée est de 16.991.8143 actions. Le Formulaire 4 a été déposé par une personne déclarant et signé par un mandataire le 12/09/2025. Le dépôt explique que ces actions ont été créditées en tant que paiement de dividendes et seront réglées conformément au plan de rémunération différée.

Hali Borenstein, eine Direktorin bei Carter's, Inc. (CRI), hat am 12.09.2025 16,8031 Stammaktien des Emittenten ohne Bareinzahlung im Rahmen des Vorstands- deferred compensation-Programms erhalten. Nach der Transaktion wird das insgesamt gemeldete beherrschende Eigentum mit 16.991.8143 Aktien angegeben. Das Formular 4 wurde von einer meldenden Person eingereicht und am 12.09.2025 von einem Prokuristen unterzeichnet. Die Einreichung erklärt, dass diese Aktien als Dividendenzahlung gutgeschrieben wurden und gemäß dem Deferred-Compensation-Plan abgewickelt werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Borenstein Hali

(Last) (First) (Middle)
3438 PEACHTREE ROAD NE
SUITE 1800

(Street)
ATLANTA GA 30326

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARTERS INC [ CRI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/12/2025 A 16.8031(1) A $0 16,991.8143 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock credited to the Reporting Person as a result of a dividend payment with respect to the Company's common stock, in accordance with and to be settled pursuant to the terms of the Company's director deferred compensation program.
Remarks:
/s/Derek Swanson, Attorney-in-Fact 09/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Hali Borenstein report on Form 4 for CRI?

The filing reports an acquisition of 16.8031 shares of Carter's, Inc. common stock on 09/12/2025, credited under the director deferred compensation program.

Was any cash paid for the shares reported by the director on this Form 4?

No; the Form 4 shows a reported price of $0, and the explanation states the shares were credited as a dividend payment under the deferred compensation plan.

How many shares does the reporting person beneficially own after the reported transaction?

The Form 4 reports a total beneficial ownership of 16,991.8143 shares following the transaction.

Does this Form 4 show option exercises or derivative transactions for CRI?

No. Table II for derivative securities shows no entries; the filing only documents a non-derivative stock credit.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by /s/ Derek Swanson, Attorney-in-Fact and dated 09/12/2025.
Carters

NYSE:CRI

CRI Rankings

CRI Latest News

CRI Latest SEC Filings

CRI Stock Data

1.16B
35.00M
3.42%
127.33%
11.64%
Apparel Retail
Apparel & Other Finishd Prods of Fabrics & Similar Matl
Link
United States
ATLANTA